Effect of Cyclodextrin Charge on Complexation of Neutral and Charged Substrates: Comparison of (SBE)7M-β-CD to HP-β-CD
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Purpose. To understand the role of charge in substrate/cyclodextrin complexation by comparing the binding of neutral and charged substrates to a neutral cyclodextrin, such as hydroxypropyl β–CD (HP–β–CD) with 3.5 degrees of substitution, and an anionically charged cyclodextrin, such as sulfobutyl ether β–CD ((SBE)7M–β–CD) with 6.8 degrees of substitution.
Method. HP–β–CD and (SBE)7M–β–CD were evaluated in their ability to form inclusion complexes with neutral compounds, as well as to cationic and anionic substrates in their charged and uncharged forms. The complexation constants (Kc) were determined via a UV spectrophotometric technique, by monitoring the change in substrate absorbance upon incremental addition of a concentrated cyclodextrin solution. The role of electrostatic interaction was probed by observing Kc as a function of solution ionic strength.
Results. Neutral molecules displayed a stronger interaction with (SBE)7M–β–CD compared to HP–β–CD. In those cases where the guest possessed a charge (positive or negative), HP–β–CD/substrate complexes exhibited a decrease in complexation strength (2 to 31 times lower) compared to the neutral forms of the same substrate. The same was true (but to a larger extent, 41 times lower) for negatively charged molecules binding to (SBE)7M–β–CD due to charge–charge repulsion. However, positively charged molecules interacting with the negatively charged (SBE)7M–β–CD displayed a similar binding capability as their neutral counterpart, due to charge–charge attraction. Further evaluation through manipulation of solution ionic strength revealed strong electrostatic interactions between substrate and cyclodextrin charges. In addition, the studies suggested that on average two sulfonates out of seven may be involved in forming ionic attraction or repulsion effects with the positive charges on prazosin and papaverine, or negative charges of ionized naproxen and warfarin.
Conclusions. Presence of charge on the cyclodextrin structure provides an additional site of interaction compared to neutral cyclodextrins, which may be modified using solution ionic strength.
- D. O. Thompson. Cyclodextrins–enabling excipients: Their present and future use in pharmaceuticals. Crit. Rev. Ther. Drug Carrier Syst. 14:1–140 (1997).
- T. Irie and K. Uekama. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86:147–162 (1997).
- J. Pitha, J. Milecki, H. Fales, L. Pannell, and K. Uekama. HP–β–CD, Preparation and characterization, effect on solubility of drugs. Int. J. Pharm. 29:73–82 (1986).
- R. A. Rajewski. Development and evaluation of the usefulness and parenteral safety of modified cyclodextrins. Ph.D. Dissertation, the University of Kansas. 1990.
- K. Shiotani, K. Uehata, T. Irie, F. Hirayama, and K. Uekama. Characterization of the inclusion mode of β–cyclodextrin sulfate and its effect on the chlorpromazine induced hemolysis of rabbit erythrocytes. Chem. Pharm. Bull. 42:2332–2337 (1994).
- B. W. Müller and U. Brauns. Solubilization of drugs by modified β–cyclodextrins. Int. J. Pharm. 26:77–88 (1985).
- M. Másson, T. Loftsson, S. Jónsdottir, H. Fridriksdóttir, and D. S. Petersen. Stabilisation of ionic drugs through complexation with non–ionic and ionic cyclodextrins. Int. J. Pharm. 164:45–55 (1998).
- V. Zia, R. A. Rajewski, E. R. Bornancini, E. A. Luna, and V. J. Stella. Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether β–cyclodextrins with steroids. J. Pharm. Sci. 86:220–224 (1997).
- V. Zia, R. A. Rajewski, and V. J. Stella. Thermodynamics of binding of neutral molecules to sulfobutyl ether β–cyclodextrins (SBE–β–CD): The effect of total degree of substitution. Pharm. Res. 17:936–941 (2000).
- Y. Matsui and A. Okimoto. The binding and catalytic properties of a positively charged cyclodextrin. Bull. Chem. Soc. Jpn. 51:3030–3034 (1978).
- V. Eliseev and H. Schneider. Aminocyclodextrins as selective hosts with several binding sites for nucleotides. Agewandte Chemie. 32:1331–1333 (1993).
- K. Okimoto, R. A. Rajewski, K. Uekama, J. A. Jona, and V. J. Stella. The interaction of charged and uncharged drugs with neutral (HP–β–CD) and anionically charged (SBE7–β–CD) β–cyclodextrins. Pharm. Res. 13:256–264 (1996).
- K. A. Connors. Binding Constants: The Measurement of Molecular Complex Stability, Wiley–Ineterscience Publication, New York, 1987 pp. 141–187.
- H.–J. Scneider, F. Hacket, and V. Rüdiger. NMR studies of cyclodextrins and cyclodextrins and cyclodextrin complexes. Chem. Rev. 98:1755–1785 (1998).
- W. P. Jencks. Catalysis in Chemistry and Enzymology, McGraw–Hill Book Company, New York, 1969 pp. 351–392.
- J. Robbins. Ions in Solution 2.: An Introduction to Electrochemistry, Clarendon Press, Oxford, 1972 pp. 1–15.
- T. Backensfeld, B. W. Müller, and K. Kolter. Interaction of NSA with cyclodextrins and hydroxypropyl cyclodextrin derivatives. Int. J. Pharm. 74:85–93 (1991)
- K. A. Connors and T. W. Rosanske. Trans–Cinnamic acid–α–cyclodextrin system as studied by solubility, spectral, and potentiometric techniques. J. Pharm. Sci. 69:173–179 (1980).
- R. Krishnamoorthy and A. K. Mitra. Complexation of weak acids and bases with cyclodextrins: Effects of substrate ionization on the estimation and interpretation of association constants. Int. J. Pharm. Advances. 1:329–343 (1996).
- I. Suzuki, Q. Chen, A. Ueno, and T. Osa. Ferrocene–Appended cyclodextrins. The effects of temperature, organic solvent, length of spacer, and cavity size on the complexation behavior. Bull. Chem. Soc. Jpn. 66:1472–1481 (1993).
- B. W. Müller and E. Albers. Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs. J. Pharm. Sci. 80:599–604 (1991).
- C. Harrison and M. R. Eftink. Cyclodextrin–Adamantanecarboxylate inclusion complexes: A model system for the hydrophobic effect. Biopolymers 21:1153–1166 (1984).
- C. D. Ritchie. Interactions in dipolar aprotic solvents. In J. F. Coetzee and C. D. Titchie (eds.), Solute–Solvent Interactions, Marcel–Dekker, New York, 1976 pp. 290–294.
- S. D. Christian and E. H. Lane. Solvent effects on molecular complex equilibria. In M. R. J. Dack (ed.), Solution and Solubilities. Part I. In Techniques in Chemistry, Vol. 8, Wiley–Interscience Publication, New York, 1975 pp. 327–378.
- H. Gutfreund. Enzymes; Physical Principles, Wiley–Interscience Publications, New York, 1972 pp. 27–52.
- F. J. C. Rossotti and H. Rossotti. The Determination of Stability Constants — and Other Equilibrium Constants in Solution, McGraw–Hill Book Company Inc., New York 1961 pp. 17–37.
- H. J. Schneider, R. Kramer, S. Simova, and U. Schneider. Solvent and salt effects on binding constants of organic substrates in macrocyclic host compounds. A general equation measuring hydrophobic binding contributions. J. Am. Chem. Soc. 110:6442–6448 (1988).
- H. J. Schneider. Mechanisms of molecular recognition:Investigations of organic host–guest complexes. Angew. Chem. Int. Ed. Engl. 30:1417–1436 (1991).
- P. Hammet. Physical Organic Chemistry: Vol. I, Reaction Rates, Equilibria and Mechanisms, McGraw–Hill Book Company, New York, 1970 pp. 187–220.
- J. O'm. Bockris and A. K. N. Reddy. Modern Electrochemistry, Plenum Press, New York, 1970 pp. 202–212.
- Effect of Cyclodextrin Charge on Complexation of Neutral and Charged Substrates: Comparison of (SBE)7M-β-CD to HP-β-CD
Volume 18, Issue 5 , pp 667-673
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- ionic strength
- coulombic interactions
- sulfobutyl cyclodextrins
- hydroypropyl cyclodextrin
- Industry Sectors
- Author Affiliations
- 1. Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Avenue, Lawrence, Kansas, 66047
- 2. Department of Formulation, Pharmacia, 4901 Searle Pkwy, Skokie, Illinois, 60077
- 3. Higuchi Biosciences Center for Drug Delivery Research, The University of Kansas, 2095 Constant Avenue, Lawrence, Kansas, 66047